Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia.

Richards JS, Stanisic DI, Fowkes FJ, Tavul L, Dabod E, Thompson JK, Kumar S, Chitnis CE, Narum DL, Michon P, Siba PM, Cowman AF, Mueller I, Beeson JG.

Clin Infect Dis. 2010 Oct 15;51(8):e50-60. doi: 10.1086/656413.

PMID:
20843207
[PubMed - indexed for MEDLINE]
Free Article
2.

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.

Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.

Infect Immun. 2009 Mar;77(3):1165-74. doi: 10.1128/IAI.01129-08. Epub 2009 Jan 12.

PMID:
19139189
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.

Reiling L, Richards JS, Fowkes FJ, Wilson DW, Chokejindachai W, Barry AE, Tham WH, Stubbs J, Langer C, Donelson J, Michon P, Tavul L, Crabb BS, Siba PM, Cowman AF, Mueller I, Beeson JG.

PLoS One. 2012;7(9):e45253. doi: 10.1371/journal.pone.0045253. Epub 2012 Sep 20.

PMID:
23028883
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria.

Reiling L, Richards JS, Fowkes FJ, Barry AE, Triglia T, Chokejindachai W, Michon P, Tavul L, Siba PM, Cowman AF, Mueller I, Beeson JG.

J Immunol. 2010 Nov 15;185(10):6157-67. doi: 10.4049/jimmunol.1001555. Epub 2010 Oct 20.

PMID:
20962255
[PubMed - indexed for MEDLINE]
Free Article
5.

Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.

Cole-Tobian JL, Michon P, Biasor M, Richards JS, Beeson JG, Mueller I, King CL.

Infect Immun. 2009 Sep;77(9):4009-17. doi: 10.1128/IAI.00158-09. Epub 2009 Jun 29.

PMID:
19564376
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.

Metzger WG, Okenu DM, Cavanagh DR, Robinson JV, Bojang KA, Weiss HA, McBride JS, Greenwood BM, Conway DJ.

Parasite Immunol. 2003 Jun;25(6):307-12.

PMID:
14507328
[PubMed - indexed for MEDLINE]
7.

Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.

al-Yaman F, Genton B, Kramer KJ, Chang SP, Hui GS, Baisor M, Alpers MP.

Am J Trop Med Hyg. 1996 May;54(5):443-8.

PMID:
8644896
[PubMed - indexed for MEDLINE]
8.

A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.

Branch OH, Udhayakumar V, Hightower AW, Oloo AJ, Hawley WA, Nahlen BL, Bloland PB, Kaslow DC, Lal AA.

Am J Trop Med Hyg. 1998 Feb;58(2):211-9.

PMID:
9502606
[PubMed - indexed for MEDLINE]
Free Article
9.

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.

King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, Zimmerman PA, Cole-Tobian JL, Mueller I, Chitnis CE.

Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8363-8. doi: 10.1073/pnas.0800371105. Epub 2008 Jun 3.

PMID:
18523022
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.

Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.

Infect Immun. 2006 Aug;74(8):4573-80.

PMID:
16861644
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers.

Krause DR, Gatton ML, Frankland S, Eisen DP, Good MF, Tilley L, Cheng Q.

Infect Immun. 2007 Dec;75(12):5967-73. Epub 2007 Oct 8.

PMID:
17923524
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

John CC, Moormann AM, Pregibon DC, Sumba PO, McHugh MM, Narum DL, Lanar DE, Schluchter MD, Kazura JW.

Am J Trop Med Hyg. 2005 Jul;73(1):222-8.

PMID:
16014863
[PubMed - indexed for MEDLINE]
Free Article
14.

Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.

Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K.

J Infect Dis. 2004 Nov 1;190(9):1527-33. Epub 2004 Sep 22.

PMID:
15478055
[PubMed - indexed for MEDLINE]
Free Article
15.

Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.

Richards JS, Arumugam TU, Reiling L, Healer J, Hodder AN, Fowkes FJ, Cross N, Langer C, Takeo S, Uboldi AD, Thompson JK, Gilson PR, Coppel RL, Siba PM, King CL, Torii M, Chitnis CE, Narum DL, Mueller I, Crabb BS, Cowman AF, Tsuboi T, Beeson JG.

J Immunol. 2013 Jul 15;191(2):795-809. doi: 10.4049/jimmunol.1300778. Epub 2013 Jun 17.

PMID:
23776179
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antibodies and Plasmodium falciparum merozoites.

Ramasamy R, Ramasamy M, Yasawardena S.

Trends Parasitol. 2001 Apr;17(4):194-7. Review.

PMID:
11282510
[PubMed - indexed for MEDLINE]
17.

Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.

Persson KE, Fowkes FJ, McCallum FJ, Gicheru N, Reiling L, Richards JS, Wilson DW, Lopaticki S, Cowman AF, Marsh K, Beeson JG.

J Immunol. 2013 Jul 15;191(2):785-94. doi: 10.4049/jimmunol.1300444. Epub 2013 Jun 17.

PMID:
23776178
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum.

Okenu DM, Riley EM, Bickle QD, Agomo PU, Barbosa A, Daugherty JR, Lanar DE, Conway DJ.

Infect Immun. 2000 Oct;68(10):5559-66.

PMID:
10992454
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum.

Touré FS, Deloron P, Migot-Nabias F.

Clin Med Res. 2006 Mar;4(1):1-6.

PMID:
16595787
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.

Persson KE, McCallum FJ, Reiling L, Lister NA, Stubbs J, Cowman AF, Marsh K, Beeson JG.

J Clin Invest. 2008 Jan;118(1):342-51.

PMID:
18064303
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk